Camilla Sylvest
Director/Board Member bei ARGENX SE
Vermögen: 88 962 $ am 31.03.2024
Profil
Ms. Camilla Sylvest is an Independent Non-Executive Director at argenx SE, an EVP-Commercial Strategy & Corporate Affairs at Novo Nordisk A/S, an Independent Director at Danish Crown A/S and a Senior Vice President & General Manager-Germany at Novo Nordisk Pharma GmbH.
She is on the Board of Directors at argenx SE, Danish Crown A/S and World Diabetes Foundation.
She received her graduate degree from the University of Southern Denmark and an MBA from Scandinavian International Management Institute.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ARGEN-X SE
0,00% | 20.02.2024 | 225 ( 0,00% ) | 88 962 $ | 31.03.2024 |
Aktive Positionen von Camilla Sylvest
Unternehmen | Position | Beginn |
---|---|---|
NOVO NORDISK A/S | Corporate Officer/Principal | 01.01.2003 |
ARGENX SE | Director/Board Member | 08.09.2022 |
Novo Nordisk Pharma GmbH
Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Corporate Officer/Principal | 18.10.2011 |
Danish Crown A/S
Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Director/Board Member | - |
World Diabetes Foundation | Director/Board Member | - |
Ausbildung von Camilla Sylvest
University of Southern Denmark | Graduate Degree |
Scandinavian International Management Institute | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
NOVO NORDISK A/S | Health Technology |
ARGENX SE | Health Technology |
Private Unternehmen | 3 |
---|---|
Novo Nordisk Pharma GmbH
Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Health Technology |
Danish Crown A/S
Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Consumer Non-Durables |
World Diabetes Foundation | Miscellaneous |